Change of role for JS CEO Ian Settle22 Dec, 20223 mins
At JS we have had the privilege of Ian Settle initially joining us as a non-exec director an...
At JS we have had the privilege of Ian Settle initially joining us as a non-exec director and latterly becoming our CEO. Ian’s remit was that of helping drive the firm‘s strategy, and it is fair to say he has certainly succeeded with that and more. Now, as we move to the next stage of our development, we have agreed that his role will switch back to that of a non-exec, still here and paramount in supporting our growth and direction.
Whilst Ian will remain a key advisor to the business, we would like to take this opportunity to say a big thank you to him for the great advancements in our business that he has helped to deliver and the support and guidance he has provided. We couldn’t have done it without him.
Ian had the following comments "When I first looked at helping JS in 2020 with the creation of a five-year strategic plan it was as a non-exec director but, once we'd started to gain some real momentum with the strategy, it made sense that I joined the firm as CEO to work alongside the leadership team to help accelerate and embed the changes. Across the whole firm, we've made some little changes, big changes, improvements, efficiencies and invested significantly in our greatest asset - our outstanding people. Due to the latter, we've created new leadership roles for Lucy Williams, James Wood, Paul Holland, and Emma Birchall, who will continue to drive JS forward, together with the existing management team.
The time is right for me to amend my job title back to NED whilst still continuing to help the team build, grow and thrive. It's been a real pleasure and honour so far, and I am delighted to remain part of this outstanding team as it continues its journey. We've achieved loads and still have plenty of exciting plans in the pipeline!!! This change also allows me to look at other possible roles alongside my JS responsibilities, which is another exciting development for me personally."